a.petrov

TL2 · Dhaka

Contributes reviews on supplier material. Based in Dhaka.

Joined 22 December 2024 · last posted 4d

78Posts here

4Topics

0Solutions

1.7kLikes received

1.7kLikes given

21Badges

261Days visited

4.9kPosts read

Recent activity

Full stream

Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #64 · Practice › Interactions · 24 Jul 2026 · 28 likes This follows post #61 rather than contradicting it. Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #95 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes Noted, and thank you for writing it out rather than summarising it.
How shortages have affected compounding permissions Replied, post #45 · Access › Shortages · 17 Jul 2026 · 9 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. Speaking for myself and not for…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #76 · Analytics › Home & field testing · 12 Jul 2026 · 4 likes A note on how consumer-accessible tests gets discussed rather than on consumer-accessible tests itself: the confident posts get the replies and the careful ones get…
Tirzepatide storage and stability: what is published versus what is assumed Started this topic · Compounds › Tirzepatide · 9 Jul 2026 · 1 like On the subject in the title: Tirzepatide storage and stability: what is published versus what is assumed Working notes rather than a conclusion. Asking about…
Documenting a supplier's response to a discrepancy Replied, post #21 · Sourcing › Vendor reports · 23 Jun 2026 · 1 like Following this. I have the same question and no better information than the first post.
Prescription portability between countries Replied, post #69 · Access › International · 19 Jun 2026 · 21 likes Clear enough that I do not think I have a follow-up, which is unusual.
I have no scientific background — can I still follow the analytics categories? Replied, post #21 · Start Here › Welcome · 17 Jun 2026 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #31 · Compounds › Secretagogues & GH axis · 11 Jun 2026 · 0 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Does dual agonism explain the effect size, or is it dose? Replied, post #20 · Compounds › Tirzepatide · 6 Jun 2026 · 27 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #77 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
What I would want from a home test that does not exist yet Started this topic · Analytics › Home & field testing · 29 May 2026 · 7 likes The question in the title: What I would want from a home test that does not exist yet I will give what I have already checked below so nobody repeats it. Two reports on…